Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA CIPLA NATCO PHARMA/
CIPLA
 
P/E (TTM) x 13.3 32.2 41.4% View Chart
P/BV x 3.5 5.2 67.6% View Chart
Dividend Yield % 0.6 0.6 101.6%  

Financials

 NATCO PHARMA   CIPLA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
CIPLA
Mar-23
NATCO PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs8471,185 71.4%   
Low Rs502852 58.9%   
Sales per share (Unadj.) Rs148.4281.9 52.6%  
Earnings per share (Unadj.) Rs39.235.1 111.6%  
Cash flow per share (Unadj.) Rs48.249.7 97.0%  
Dividends per share (Unadj.) Rs5.508.50 64.7%  
Avg Dividend yield %0.80.8 97.7%  
Book value per share (Unadj.) Rs267.1289.2 92.3%  
Shares outstanding (eoy) m182.47807.15 22.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.53.6 125.8%   
Avg P/E ratio x17.229.0 59.3%  
P/CF ratio (eoy) x14.020.5 68.2%  
Price / Book Value ratio x2.53.5 71.7%  
Dividend payout %14.024.2 58.0%   
Avg Mkt Cap Rs m123,049822,164 15.0%   
No. of employees `000NANA-   
Total wages/salary Rs m4,86738,301 12.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,071227,531 11.9%  
Other income Rs m1,2855,121 25.1%   
Total revenues Rs m28,356232,653 12.2%   
Gross profit Rs m9,11748,079 19.0%  
Depreciation Rs m1,63811,721 14.0%   
Interest Rs m1451,095 13.2%   
Profit before tax Rs m8,61940,384 21.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,46612,029 12.2%   
Profit after tax Rs m7,15328,355 25.2%  
Gross profit margin %33.721.1 159.4%  
Effective tax rate %17.029.8 57.1%   
Net profit margin %26.412.5 212.0%  
BALANCE SHEET DATA
Current assets Rs m30,003168,051 17.9%   
Current liabilities Rs m6,83150,333 13.6%   
Net working cap to sales %85.651.7 165.4%  
Current ratio x4.43.3 131.5%  
Inventory Days Days6373 86.6%  
Debtors Days Days1157 1,773.6%  
Net fixed assets Rs m26,571117,318 22.6%   
Share capital Rs m3651,614 22.6%   
"Free" reserves Rs m48,373231,845 20.9%   
Net worth Rs m48,738233,460 20.9%   
Long term debt Rs m00-   
Total assets Rs m56,574290,067 19.5%  
Interest coverage x60.437.9 159.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.8 61.0%   
Return on assets %12.910.2 127.1%  
Return on equity %14.712.1 120.8%  
Return on capital %18.017.8 101.2%  
Exports to sales %022.6 0.0%   
Imports to sales %10.28.9 115.3%   
Exports (fob) Rs mNA51,516 0.0%   
Imports (cif) Rs m2,77220,202 13.7%   
Fx inflow Rs m17,25664,282 26.8%   
Fx outflow Rs m2,77220,202 13.7%   
Net fx Rs m14,48444,080 32.9%   
CASH FLOW
From Operations Rs m8,49132,377 26.2%  
From Investments Rs m-4,771-23,885 20.0%  
From Financial Activity Rs m-3,630-9,583 37.9%  
Net Cashflow Rs m208-968 -21.5%  

Share Holding

Indian Promoters % 49.7 13.4 370.1%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 25.0 50.0 49.9%  
FIIs % 13.7 25.7 53.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 66.5 75.6%  
Shareholders   207,571 425,731 48.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Natco Pharma vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs Cipla Share Price Performance

Period Natco Pharma Cipla S&P BSE HEALTHCARE
1-Day -2.11% 1.94% 1.18%
1-Month -3.19% 1.25% -0.75%
1-Year 72.80% 68.02% 61.82%
3-Year CAGR 4.96% 22.53% 18.16%
5-Year CAGR 10.96% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.